National Health and Family Planning Commission: has provided 300 million yuan to support "cheap life-saving medicine"

Source: Health times January 19, 2018 Recently, the state health and Family Planning Commission issued a letter on the official website to reply to the proposal of putting the supply guarantee of "cheap and life-saving" old drugs on the agenda as soon as possible The reply said that in recent years, the Ministry of industry and information technology, jointly with the development and Reform Commission and the Ministry of Finance and other departments, has given support to GMP transformation of pharmaceutical manufacturers in short supply through relevant industrialization special projects, and specialized in industrial revitalization and technological transformation In the project, the expansion and transformation of clinical drugs in short supply, rare disease drugs and children's drugs were taken as the support focus, and a total of 30 projects were supported to implement technical transformation, with a capital of about 300 million yuan Reform and improve the guarantee mechanism of short supply of drugs In the next step, the national health and Family Planning Commission, the national development and Reform Commission, the Ministry of industry and information technology, the Ministry of finance, the Ministry of human resources and social security, the Ministry of Commerce, the state owned assets supervision and administration of industry and commerce, the State Food and drug administration and other agencies will form a national conference and linkage mechanism for the supply of drugs in short supply, highlighting cross domain and multi sector policy coordination, cooperation and effective linkage, and clarifying the work rules In order to improve the government's ability to guarantee the supply of drugs that are necessary for clinical use, small dosage and lack of motive power, we should make use of fixed-point production, emergency production and import coordination, improve the pharmaceutical reserve system, connect supply and demand information, crack down on misconduct and improve the drug policy for rare diseases The provincial health and family planning departments shall focus on coordinating relevant departments to establish corresponding consultation and linkage mechanism, comprehensively evaluate the drug shortage information and response suggestions within the jurisdiction, and comprehensively solve the local shortage problem We will focus on strengthening the three levels of monitoring at the provincial, municipal and county levels, analyzing, processing and reporting shortage information in a timely manner, and enhancing the comprehensive response capacity On the policy of supporting the production of cheap drugs In recent years, the Ministry of industry and information technology, together with the development and Reform Commission, the Ministry of Finance and other departments, has given support to the GMP transformation of drug manufacturers in short supply through relevant industrialization projects In the special projects of industrial revitalization and technological transformation, the expansion and transformation of clinical drugs in short supply, rare disease drugs and children's drugs have been the focus of support A total of 30 projects have been supported for technological transformation, with a capital of about 300 million yuan In 2016, Through the "three products" project of the industrial transformation and upgrading fund for consumer goods, special support was given to innovative products such as new drugs, new vaccines, appropriate dosage forms and specifications for children, and industrialization of drugs for children in clinical shortage, with a total subsidy of 80 million yuan According to the current policy, qualified low-cost drug manufacturers can obtain corresponding support policies in terms of bank loans The current enterprise income tax law provides a series of preferential income tax policies to encourage scientific and technological innovation, including those identified as high-tech enterprises, the enterprise income tax can be levied at a reduced rate of 15%; the research and development expenses actually incurred by enterprises that meet the requirements can be deducted on the basis of the facts, plus 50% before income tax; The qualified fixed assets of an enterprise can be depreciated more quickly, and the qualified small low profit enterprises can enjoy such preferential policies as halving the enterprise income tax Qualified low-cost drug manufacturers can enjoy the above tax preference in accordance with the law Chinese herbal medicine planting, processing and other projects are in line with the support scope of agricultural comprehensive development, and play an important role in promoting local agricultural efficiency and farmers' income Since 2016, the National Agricultural Development Office has required all regions to vigorously support the agricultural advantageous characteristic industries and strive to make the regional advantageous characteristic industries bigger and stronger in accordance with the actual situation and the planning requirements of agricultural comprehensive development and supporting the agricultural advantageous characteristic industries It is understood that some provinces have listed the Chinese herbal medicine industry in their local planning, and have taken financial subsidies, loan discount and other ways to support the Chinese herbal medicine planting and processing projects declared by all kinds of new agricultural business entities that meet the requirements of relevant regulations For projects such as planting and processing of "low-cost life-saving" drug raw materials in line with the provisions of the comprehensive agricultural development policy, support can be applied to the local agricultural development agency.